Walden Group Healthcare M&A Blog

  • Robotics Remain an Active M&A Area

    11/4/2019
    Earlier in 2019, Johnson & Johnson paid $3.4b (plus up to an additional $2.35b) for Auris Health, Inc., a maker of endoscopic robotic technologies. The Auris platform complements robotics currently in development for general surgery by Verb Surgical, a startup founded by J&J and Verily Life Sciences (an Alphabet unit), and for orthopedics...
    Read More
  • FDA Grants Breakthrough Device Designation to Medtronic’s Minimally Invasive Valiant TAAA Stent Graft System

    10/10/2019
    The new Valiant TAAA Stent Graft System is designed to repair a thoracoabdominal aortic aneurysm (TAAA). A TAAA causes swelling of the aorta, which extends from the chest into the abdomen. Commonly, TAAA affects the branch arteries supplying blood to various internal organs. The condition accounts for approximately 15% of all thoracic aneurysms....
    Read More
  • Celgene to Sell Blockbuster Drug to Amgen for $13.4b

    08/26/2019
    Amgen Inc., a $23b multinational biopharmaceutical company is buying the worldwide rights to Otezla® from Celgene Corporation, a $13b developer of therapies for cancer and inflammatory diseases, for $13.4b. The acquisition complements Amgen's existing inflammation franchise of innovative biologics and biosimilar products. Otezla® (apremilast) is...
    Read More
  • Exact Sciences to buy Genomic Health for $2.8b

    7/29/2019
    Exact Sciences Corp, a $454m molecular diagnostics company is acquiring Genomic Health Inc, a $394m cancer detection company for $2.8b. The deal joins two of the strong brands in molecular and cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth; and forms a first class commercial, research,...
    Read More
  • Cantel Medical to Acquire Hu-Friedy for $725m

    07/30/2019
    Cantel Medical Corp., a $880m manufacturer of medical equipment announced plans to buy Hu-Friedy Mfg. Co., a maker of dental instruments and reprocessing equipment for $725m. The deal helps build out a portfolio of infection prevention solutions including consumables, instrumentation and workflow management programs for dental practitioners while...
    Read More